A PHASE 2 STUDY TO ASSESS THE SAFETY, EFFICACY OF FLX475 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC GASTRIC CANCER

Authors
Category Primary study
JournalJournal for ImmunoTherapy of Cancer
Year 2022
This article has no abstract
Epistemonikos ID: a8f188bcca52bc90f362d8829231c1a3bb48bcca
First added on: Feb 15, 2025